Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it Life sciences companies are putting all of their efforts into finding a treatment or developing a vaccine for this disease PharmaShots is keeping a track of all of the important updates in the Life-sciences […]Read More
The global generics pharmaceutical market has become an intimidating segment of the pharmaceutical drug market which continuously growing and increasing with its accessibility & benefits offered as efficient and economical drugs. Generics are approved copies of small molecule drugs that contain the same amount of active ingredients, dosage form, safety, strength, route of administration, quality, […]Read More
The global generics pharmaceutical market is continuously growing and increasing with its accessibility & benefits offered as efficient and economical drugs, are always needed in the market. Generics are approved copies of small molecule drugs which contain the same amount of active ingredients, dosage form, safety, strength, route of administration, quality, performance characteristics, as of […]Read More
Shots: Novartis sells a part of Sandoz US, which includes ~300 products that generated $0.6B in H1’18 This transaction includes development projects along with ~300 products to Aurobindo Pharma USA Inc. for $0.9B in cash & $0.1B of potential earn-outs, with expected closure in 2019 Aurobindo will also take over manufacturing facilities in Wilson, North […]Read More
Copyright ©2021 PharmaShots | Powered by Octavus Consulting
